Chaguturu Sreekanth K 4
4 · CVS HEALTH Corp · Filed Dec 1, 2022
Insider Transaction Report
Form 4
Chaguturu Sreekanth K
EVP and Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2022-11-29$100.88/sh−442$44,589→ 2,896.78 total
Holdings
- 1,258
Common Stock (RSU)
- 354
Common Stock (RSU)
- 2,154
Common Stock (RSU)
- 6,182
Common Stock (RSU)
- 9,579
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (9,579 underlying) - 9,502
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (9,502 underlying) - 2,085
Common Stock (RSU)
- 2,776
Common Stock (RSU)
- 12,735
Common Stock (RSU)
- 4,956
Stock Option
Exercise: $75.27From: 2020-11-29Exp: 2029-11-29→ Common Stock (4,956 underlying) - 12,993
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (12,993 underlying)
Footnotes (12)
- [F1]Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
- [F10]Option became exercisable in four equal annual installments, commencing 4/1/2021.
- [F11]Option became exercisable in four equal annual installments, commencing 4/1/2022.
- [F12]Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
- [F2]Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse on 2/28/2023.
- [F3]Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
- [F4]Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
- [F5]Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments beginning 2/26/2023.
- [F6]Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in three equal installments beginning 4/1/2023.
- [F7]Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments beginning 4/1/2023.
- [F8]Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date.
- [F9]Option became exercisable in four equal annual installments, commencing 11/29/2020.